作者: Mario S??nchez-Borges , Arnaldo Capriles-Hulett , Fernan Caballero-Fonseca
DOI: 10.1097/01.MJT.0000125121.35422.B4
关键词: Drug 、 Medical prescription 、 Aspirin 、 Pharmacology 、 Patient management 、 Asthma 、 Analgesic 、 Antipyretic 、 Cyclooxygenase 、 Medicine 、 Pharmacology (medical) 、 General Medicine
摘要: Coxibs, selective inhibitors of arachidonic acid cyclooxygenase-2, constitute a new, clinically useful therapeutic class drugs that possess analgesic, antiinflammatory, and antipyretic properties. The drug inserts prescription information presently provide warning contraindicating their use in patients with aspirin-intolerant asthma aspirin NSAID hypersensitivity. However, according to investigations reported until now, most those NSAID-sensitive individuals will tolerate coxibs. Careful oral challenge is for patient management since some cutaneous systemic reactions hypersensitivity, especially when sulfonamide-containing coxibs are employed, may occur.